Quantcast

Latest Thoratec Corporation Stories

2014-07-21 16:26:19

PLEASANTON, Calif., July 21, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter of fiscal year 2014 on Wednesday, August 6. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2014-07-02 16:24:45

PLEASANTON, Calif., July 2, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has acquired Apica Cardiovascular Limited ("Apica") for an upfront cash payment of $35 million and potential future clinical and sales milestones of up to $40 million. As part of the agreement, the Apica team based at facilities in Ireland and the United States will...

2014-06-27 08:25:53

PLEASANTON, Calif., June 27, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE Mark Clinical Trial for HeartMate III(TM) commenced with the first patient implanted with this new device. "We are pleased to reach this significant clinical milestone with an important pipeline product," said Gary F. Burbach, President and Chief Executive...

2014-06-03 08:32:48

PLEASANTON, Calif., June 3, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in three upcoming investor conferences. On Tuesday, June 10, the company will participate in the Goldman Sachs 35(th) Annual Global Healthcare Conference. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the...

2014-05-06 16:32:47

-Revenue of $125.7 million for the first quarter of 2014 PLEASANTON, Calif., May 6, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, today reported its financial results for the first quarter of 2014. "Our operational and financial progress in the first quarter provides a solid foundation for a successful 2014," said Gary F. Burbach, President and...

2014-04-30 16:31:17

PLEASANTON, Cailf., April 30, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Bank of America Merrill Lynch 2014 Healthcare Conference on Tuesday, May 13. Gary F. Burbach, President and Chief Executive Officer, will provide an update on the company, beginning at 3:00 p.m., Pacific Daylight Time (6:00 p.m., Eastern...

2014-04-14 16:25:55

PLEASANTON, Calif., April 14, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first quarter of fiscal year 2014 on Tuesday, May 6. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Daylight...

2014-03-17 16:28:56

PLEASANTON, Calif., March 17, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II(®) LVAS Pocket System Controller (the "Pocket Controller"). The following information is provided as a reinforcement of the initial release. Failure to completely connect the driveline during the process of exchanging Pocket System Controllers has resulted in serious...

2014-03-04 16:26:01

PLEASANTON, Calif., March 4, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II(®) LVAS Pocket System Controller (the "Pocket Controller"). This safety advisory is being issued because some patients and caregivers have experienced difficulties with the process of changing from a primary system controller to their backup system controller. These...

2014-02-26 12:26:13

PLEASANTON, Calif., Feb. 26, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences. On Monday, March 3, the company will participate in the Raymond James 35(th) Annual Institutional Investors Conference. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related